Integrated care clinical Pharmacist GSTT@home service

"The ICCPs have made a significant impact in the overall quality of care that the GSTT @home service patients have received, and have also had a positive effect on the overall medicines optimisation of the service in general."

Integrated care clinical Pharmacist GSTT@home service
Guys & St Thomas NHS Foundation Trust (Community Health Services) NHS Specialist Pharmacy services

NICE Shared Learning examples
September 2015

Read more here.

A Medicines Optimisation Service

"The service was developed as a result of a pilot in one practice who used innovation funding to employ a pharmacist to improve their management of medicines. The idea came from the GPs who felt they were always rushed when looking at discharge medicines and this task would be more efficiently and effectively undertaken by a pharmacist. "

A Medicines Optimisation Service
Wyre Forest Clinical Commissioning Group
NICE Shared Learning example
May 2015

Read more here.

Medicine optimisation can cut the costs of long term conditions

"Medicines optimisation can cut waste, emergency admissions and the cost of long term conditions. But a review of rheumatoid arthritis care reveals how far it has to go"

Medicine optimisation can cut the costs of long term conditions
M Shelley
Health Service Journal Supplement
June 2015

Read more here.

Medicines Optimisation Peer Review Programme

"The aim of Medicines Optimisation Peer Reviews is to influence prescribers and their decision making processes to ensure evidence-based, safe, cost effective prescribing ensuring optimal clinical outcomes for Wigan patients."

Medicines Optimisation Peer Review Programme - engaging GP practices to deliver medicines optimisation and implement NICE guidance
Wigan Borough Clinical Commissioning Group
NICE Shared Learning
March 2015

Read more here.

Advice from NICE on Medicines Optimisation of Key Therapies

NICE have released a number of evidence-based Key Therapeutic Topics to support medicines optimisation. Access them below:

• Antibiotic prescribing – especially broad spectrum antibiotics (KTT9)
• First-choice antidepressant use in adults with depression or generalised anxiety disorder (KTT8) 
• Low-dose antipsychotics in people with dementia (KTT7)
• Hypnotics (KTT6)
• High-dose inhaled corticosteroids in asthma (KTT5)
• Omega-3 fatty acid supplements (KTT4)
• Lipid-modifying drugs (KTT3)
• Renin-angiotensin system drugs (KTT2)
• Wound care products (KTT14)
• Non-steroidal anti-inflammatory drugs (KTT13)
• Type 2 diabetes mellitus (KTT12)
• Minocycline (KTT11)
• Three-day courses of antibiotics for uncomplicated urinary tract infection
• Laxatives (KTT1)

Medicines optimisation prototype dashboard

“Medicines Optimisation Prototype Dashboard” brings together a range of medicines-related data in a way never previously done. We hope it will help CCGs explore how well their local populations are supported to optimise medicines use. The dashboard is presented to allow local NHS organisations to develop improvements"

Medicines optimisation - CCG prototype dashboard

NHS England

Read more here. 

New medicines, better medicines, better use of medicines

"The Guide ... highlights the major challenges and opportunities faced when creating new medicines, improving existing medicines or ensuring the better, safer use of medicines, and makes recommendations and calls for action."

New medicines, better medicines, better use of medicines: a guide to the science underpinning pharmaceutical practice 
Royal Pharmaceutical Society
May 2014

Read more here.

Medicines optimisation: helping patients to make the most of medicines

"Medicines optimisation is about ensuring that the right patients get the right choice of medicine, at the right time."

Medicines optimisation: helping patients to make the most of medicines
Royal Pharmaceutical Society
May 2013

Read more here.